# FDA Inspection 1222671 - BeiGene, USA Inc. - November 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/beigene-usa-inc/3df9d586-21ad-48a7-8ec6-30d31fd1cafd
Source feed: FDA_Inspections

> FDA Inspection 1222671 for BeiGene, USA Inc. on November 13, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222671
- Company Name: BeiGene, USA Inc.
- Inspection Date: 2023-11-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/beigene-usa-inc/4aa7a574-c42e-4523-9af7-37a954652780

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c